AIIA	angiotensin II receptor antagonists
ACEi	angiotensin converting enzyme inhibitors
AE	adverse effects
AKT	protein kinase B
ATC	anaplastic thyroid cancer
CCB	calcium channel blockers
cGMP	cyclic guanosine monophosphate
DTC	differentiated thyroid cancer
EGF	endothelial growth factor
eNOS	endothelial nitric oxide synthase
ERK	extracellular signal regulated kinase
ET-1	endothelin-1
ETA	endothelin receptor type A
FGF	fibroblast growth factor
FGFR	fibroblast growth factor receptor
FTC	follicular thyroid cancer
MAPKK	mitogen activated protein kinase kinase
MTC	medullary thyroid cancer
NO	nitric oxide
PDGF	platelet derived growth factor
PDGFR	platelet derived growth factor receptor
PI3K	phosphatidylinositol-3-kinase
PDTC	poorly differentiated thyroid cancer
PO	per os
PTC	papillary thyroid cancer
RAI	radioactive iodine
RAS	rat sarcoma
RET	ret proto-oncogene
sGC	soluble guanylyl cyclase
TKI	tyrosine kinase inhibitor
VEGF	vascular endothelial growth factor
VEGFR	vascular endothelial growth factor receptor